Actively Recruiting
A Multicenter Prospective Observational Study of Breast Cancer Based on a Medical Record Database in China
Led by Fudan University · Updated on 2024-09-19
20000
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a multi-center observational study in China to collect and analyze information on breast cancer diagnosis, treatment, and prognosis. The study aims to evaluate differences among various regions and hospitals, and to provide data that supports guideline development, quality standards, specialized training, health insurance policy formulation, and clinical research in breast cancer care. This study does not involve changing or adding treatments but instead collects data through a prospective medical record database. It tracks the occurrence, treatment processes, and outcomes of breast cancer patients over time without intervening in their care. The study is designed to monitor patients from diagnosis and throughout their treatment and follow-up. Participants provide data that researchers use to assess the types of breast cancer treatments received and the patients' prognoses, including survival and recurrence. Outcomes are monitored for up to 100 months after diagnosis. The study also aims to publish annual reports and facilitate data sharing to improve breast cancer care quality across China.
CONDITIONS
Brief Title
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with malignant breast tumors diagnosed by cytology or histology
- Pathological types include breast carcinoma in situ, invasive carcinoma, and breast sarcoma
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 100 months
Participants who undergo routine care are observed for diagnosis, treatment, and prognosis of breast cancer based on medical records.
Visits as part of routine clinical care; no additional trial visits are required
Trial Site Locations
Total: 1 location
1
Cancer Hospital/ Institute, Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
J
Jiong Wu, M.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here